Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

Gaël Chételat(Inserm), Alexander Drzezga(Forschungszentrum Jülich), Ian Law(University of Copenhagen), Satoshi Minoshima(University of Utah), Javier Arbizu(Clinica Universidad de Navarra), Federica Agosta(Vita-Salute San Raffaele University), Anders M. Fjell(University of Oslo), Rik Ossenkoppele(Malmö University), Philip Scheltens(Amsterdam University Medical Centers), Henryk Barthel(Leipzig University), Valentina Garibotto(University of Geneva), Elsmarieke van de Giessen(Amsterdam Neuroscience), David J. Brooks(Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Oskar Hansson(Eli Lilly (United States)), Giovanni B. Frisoni(University of Geneva), Gil D. Rabinovici(University of California, San Francisco), Karl Herholz(University of Manchester), Victor L. Villemagne(The University of Melbourne), Brian Hutton(Ottawa Hospital), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Adriaan A. Lammertsma(University Medical Center Groningen), Flavio Nobili(Alleanza Contro il Cancro), Daniela Perani(San Raffaele University of Rome), Henrik Zetterberg(University of Wisconsin–Madison), Silvia Morbelli(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Agneta Nordberg(Karolinska Institutet), Marı́a C. Carrillo(Alzheimer's Association), Bruno Dubois(Portland State University), Wim J.G. Oyen(Humanitas University), Susan Landau(Mount Sinai Hospital), Clifford R. Jack(Mayo Clinic)
The Lancet Neurology
October 21, 2020
Cited by 535


Related Papers